Patients suspended unreliable drugs trial on 60 Ukrainian people

For more than a year already international and patient organizations tried to get precise information from Mili Healthcare pharmaceutical company about their new biosimilar product Peginterferon for HCV treatment. This drug was registered […]

Meeting with ViiV/GSK

During the meeting of UCAB members and state bodies’ representatives for the first time an agreement on the inclusion of patients into the group under the Ministry of Health of Ukraine (MoH) responsible for the list […]

Meeting with MSD

WHO prequalification should be an obligatory condition for the state procurements of generic medications

Meeting with ABBOTT

The first meeting of Ukrainian Community Advisory Board (UCAB) and the representatives of pharmaceutical company took place on April, 19-21. The first company, who met the community, was Abbott Laboratories Ltd.

Meeting with Gilead

During the meeting of Ukrainian Community Advisory Board (UCAB) with the representatives of Gilead Sciences, an opportunity to supply in-kind drugs donation for more than 3,000 Ukrainian patients living with HIV was discussed.

Presentation meeting UCAB

New player in pharmaceutical market of Ukraine On January 31-st the first open meeting of UCAB — a specialized board of patients for lobbying their interests in front of pharmaceutical companies — took place.